Payroll Manager
Revolution Medicines
Payroll Manager
Revolution Medicines
Clinical-stage oncology company developing RAS inhibitors
Revolution Medicines is a global, commercial-state oncology company dedicated to discovering, developing and delivering innovative medicines for patients with RAS-addicted cancers. Leveraging its differentiated RAS(ON) tri-complex inhibitor platform, the company is advancing a broad, integrated portfolio of oral RAS(ON) inhibitors designed to directly target the active, cancer-driving state of RAS. Founded on rigorous scientific inquiry and a willingness to challenge long-held assumptions, Revolution Medicines is committed to changing the trajectory of disease for patients with RAS-addicted cancers worldwide.
Our people are united by a shared way of working: follow the science, challenge assumptions, act with urgency and hold ourselves to a high standard of rigor—all in service of patients.
The Opportunity:
Reporting to the Associate Director, Payroll, the Payroll Manager will be responsible for ensuring accurate, timely and compliant payroll processing from start to finish. This position is ideal for a payroll leader who thrives in fast-paced, ambiguous, and rapidly growing environments. The successful candidate will have deep experience in public company environments, understand stock compensation, and be well-versed in SOX compliance, audits, and employment tax.
Responsibilities:
Manage full-cycle operations for the US payroll including but not limited to semi-monthly, equity, commission, off-cycle and bonus processing using ADP Workforce Now.
Support equity compensation processing including RSU, ISO, Non-Qual, and ESPP; ensuring accurate tax treatment and timely reporting.
Supervise and mentor a team of payroll professionals, providing leadership, development, and training.
Lead quarter-end and year-end payroll processes, including tax reporting, compliance filings and W-2/equivalent statement delivery.
Ensure compliance with local payroll, tax, and labor regulations in all jurisdictions.
Serve as the payroll system expert, overseeing day-to-day system integrations and collaborating with the HR team to maintain data integrity.
Collaborate with internal stakeholders (HR, Benefits, Compensation, Stock Admin, Tax Team, and Accounting) to optimize end-to-end payroll-related processes and issue resolution.
Oversee payroll-related audits, compliance checks, and controls (SOX, internal, and external audits).
Drive continuous improvement and implement solutions to operational challenges, ensuring issues are resolved quickly and effectively.
Act as the escalation point for complex payroll issues, audits, and employee inquiries.
Required Skills, Experience and Education:
Bachelor’s degree in Finance, Accounting, Economics, Business or related field.
10+ years of progressive payroll experience with 3+ years in a leadership or management role.
Public company experience with strong understanding of SOX, audit, and compliance.
Hands-on experience with ADP Workforce Now.
Ability to work independently, protect and safeguard confidential information, great attention to detail.
Strong project management skills with the ability to anticipate events, prioritize assignments, deal with interruptions, and meet deadlines in a fast-paced and growth-oriented environment.
Proven track record of training, coaching and developing high-performing teams.
Excellent written and verbal communication skills to work with interdepartmental teams.
Preferred Skills:
Pharmaceutical or biotechnology industry experience.
International payroll experience is a plus.
#LI-Hybrid #LI-YG1
The base pay salary range for this full-time position for candidates working onsite at our headquarters in Redwood City, CA is listed below. The range displayed on each job posting is intended to be the base pay salary range for an individual working onsite in Redwood City and will be adjusted for the local market a candidate is based in. Our base pay salary ranges are determined by role, level, and location. Individual base pay salary is determined by multiple factors, including job-related skills, experience, market dynamics, and relevant education or training.
Please note that base pay salary range is one part of the overall total rewards program at RevMed, which includes competitive cash compensation, robust equity awards, strong benefits, and significant learning and development opportunities.
Revolution Medicines is an equal opportunity employer and prohibits unlawful discrimination based on race, color, religion, gender, sexual orientation, gender identity/expression, national origin/ancestry, age, disability, marital status, medical condition, and veteran status.
Revolution Medicines takes protection and security of personal data very seriously and respects your right to privacy while using our website and when contacting us by email or phone. We will only collect, process and use any personal data that you provide to us in accordance with our CCPA Notice and Privacy Policy. For additional information, please contact [email protected].
We are aware of recent recruitment scams in which individuals or organizations falsely represent themselves as being affiliated with Revolution Medicines. These scams may appear as false job advertisements or unsolicited contacts through communication or chat platforms, email, phone, or text message.
Please note that Revolution Medicines does not extend unsolicited employment offers and will never ask candidates to provide financial information, purchase equipment, or pay fees as part of the hiring process. All legitimate communication from Revolution Medicines will come from an official @revmed.com email address.
If you believe you’ve been contacted by someone impersonating a Revolution Medicines recruiter, please report it to [email protected] so we can share these impersonations with our IT team for tracking and awareness.
Base Pay Salary Range 143000 - 178000 USD
Clinical-stage oncology company developing RAS inhibitors
Revolution Medicines develops precision oncology drugs focused on cancers driven by RAS mutations. Its RAS(ON) inhibitors are small molecules that bind the active form of RAS to block cancer signaling, with candidates like Daraxonrasib (RMC-6236), Elironrasib (RMC-6291), and Zoldonrasib (RMC-9805) advancing in global Phase 3 trials. The company funds its research through collaborations, royalties, and upfront funding, and has not yet marketed a product. Its goal is to bring effective RAS-targeted therapies to patients and advance multiple candidates through late-stage trials toward approval, supported by strong cash reserves.
Explore more opportunities at Revolution Medicines